{
    "Trade/Device Name(s)": [
        "CareSens N POP Blood Glucose Monitoring System"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K120351",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083468"
    ],
    "Regulatory Class": "Class II, Class I",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "April 2, 2012",
    "Summary Letter Received Date": "April 4, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "CareSens N POP Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric method",
        "Glucose oxidase (Aspergillus sp.)"
    ],
    "Methodologies": [
        "Electrochemical detection"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device",
        "Lancets"
    ],
    "Document Summary": "FDA 510(k) summary for CareSens N POP Blood Glucose Monitoring System for self-testing glucose in capillary whole blood using amperometric electrochemical method",
    "Indications for Use Summary": "Intended for self-testing at home by people with diabetes for quantitative measurement of glucose in capillary whole blood from the fingertip and alternative sites, as an aid in monitoring diabetes control; not for diagnosis, screening, or use on neonates.",
    "fda_folder": "Clinical Chemistry"
}